These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
306 results:

  • 1. A novel peptide derived from Zingiber cassumunar rhizomes exhibits anticancer activity against the colon adenocarcinoma cells (Caco-2) via the induction of intrinsic apoptosis signaling.
    Promsut K; Sangtanoo P; Srimongkol P; Saisavoey T; Puthong S; Buakeaw A; Reamtong O; Nutho B; Karnchanatat A
    PLoS One; 2024; 19(6):e0304701. PubMed ID: 38870120
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of the safety of Levilactobacillus brevis CNCM I-5321, a probiotic candidate strain isolated from pulque with anti-proliferative activities.
    Torres-Maravilla E; Boucard AS; Al Azzaz J; Gontier S; Kulakauskas S; Langella P; Bermúdez-Humarán LG
    Benef Microbes; 2023 Sep; 14(4):335-348. PubMed ID: 38661393
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway.
    Ye Q; Zhu Y; Shi M; Lv L; Gong Y; Zhang L; Yang L; Zhao H; Zhao C; Xu H
    Chin J Nat Med; 2024 Apr; 22(4):318-328. PubMed ID: 38658095
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study].
    Zhang SQ; Wu ZQ; Huo BW; Xu HN; Zhao K; Jing CQ; Liu FL; Yu J; Li ZR; Zhang J; Zang L; Hao HK; Zheng CH; Li Y; Fan L; Huang H; Liang P; Wu B; Zhu JM; Niu ZJ; Zhu LH; Song W; You J; Yan S; Li ZY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):247-260. PubMed ID: 38532587
    [No Abstract]    [Full Text] [Related]  

  • 5. BCL-X
    Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
    Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in colorectal cancer.
    Singh H; Sahgal P; Kapner K; Corsello SM; Gupta H; Gujrathi R; Li YY; Cherniack AD; El Alam R; Kerfoot J; Andrews E; Lee A; Nambiar C; Hannigan AM; Remland J; Brais L; Leahy ME; Rubinson DA; Schlechter BL; Meyerson M; Kuang Y; Paweletz CP; Lee JK; Quintanilha JCF; Aguirre AJ; Perez KJ; Huffman BM; Rossi H; Abrams TA; Kabraji S; Trusolino L; Bertotti A; Sicinska ET; Parikh AR; Wolpin BM; Schrock AB; Giannakis M; Ng K; Meyerhardt JA; Hornick JL; Sethi NS; Cleary JM
    Clin Cancer Res; 2024 Apr; 30(8):1669-1684. PubMed ID: 38345769
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The mechanism of anticancer effects of some pyrrolopyrimidine derivatives on HT-29 human colon cancer cells.
    Ergul M; Kilic-Kurt Z; Aka Y; Kutuk O; Sahin-Inan ZD
    Toxicol In Vitro; 2024 Mar; 95():105757. PubMed ID: 38061602
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial cancer.
    Dos Santos JTT; Rosa RCA; Pereira ALE; Assunção-Luiz AV; Bacalá BT; Ferraz VEF; Flória M
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002942
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
    Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dual targeting of mcl-1 and Bcl-2 to overcome chemoresistance in cervical and colon cancer.
    Wang L; Xi C; Liu R; Ye T; Xiang N; Deng J; Li H
    Anticancer Drugs; 2024 Mar; 35(3):219-226. PubMed ID: 37948336
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
    Zhang J; Li C; Sun L; Sun D; Zhao T
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers.
    McLoughlin EC; Twamley B; O'Brien JE; Hannon Barroeta P; Zisterer DM; Meegan MJ; O'Boyle NM
    Bioorg Chem; 2023 Dec; 141():106877. PubMed ID: 37804699
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Domino Liver Transplantation for Unresectable Colon cancer Liver Metastasis From a Donor With Heterozygous Familial Hyperlipidemia: A Case Report.
    Sambommatsu Y; Bruno DA; Imai D; Lee SD; Khan AA; Sharma A; Saeed M; Cotterell AH; Levy MF; Bhati C; Kumaran V
    Transplant Proc; 2023 Oct; 55(8):1930-1933. PubMed ID: 37661467
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutual association between family history of gastric and colorectal cancer and risk of gastric and colorectal cancer.
    Jung YS; Tran MTX; Park B; Moon CM
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1787-1793. PubMed ID: 37259229
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
    Guzauskas GF; Garbett S; Zhou Z; Schildcrout JS; Graves JA; Williams MS; Hao J; Jones LK; Spencer SJ; Jiang S; Veenstra DL; Peterson JF
    Ann Intern Med; 2023 May; 176(5):585-595. PubMed ID: 37155986
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Intensification of Local Therapy With High Dose Rate, Intraoperative Radiation Therapy (HDR-IORT) and Extended Resection for Locally Advanced and Recurrent colorectal cancer.
    Agas RAF; Tan J; Xie J; Van Dyk S; C H Kong J; Heriot A; Ngan SY
    Clin Colorectal Cancer; 2023 Sep; 22(3):257-266. PubMed ID: 37100642
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sphingosine kinase-2 silencing modulates sensitivity of HT-29 human colorectal cancer cells to paclitaxel-induced cell death through altering apoptosis-related proteins.
    Mu Y; Wang J; Li G
    Chem Biol Drug Des; 2023 Aug; 102(2):255-261. PubMed ID: 36929215
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence.
    Hassanin E; Spier I; Bobbili DR; Aldisi R; Klinkhammer H; David F; Dueñas N; Hüneburg R; Perne C; Brunet J; Capella G; Nöthen MM; Forstner AJ; Mayr A; Krawitz P; May P; Aretz S; Maj C
    BMC Med Genomics; 2023 Mar; 16(1):42. PubMed ID: 36872334
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. STAT3 regulates 5-Fu resistance in human colorectal cancer cells by promoting mcl-1-dependent cytoprotective autophagy.
    Yue Y; Zhang Q; Wang X; Sun Z
    Cancer Sci; 2023 Jun; 114(6):2293-2305. PubMed ID: 36788743
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Combined inhibition of aurora kinases and Bcl-xL induces apoptosis through select BH3-only proteins.
    Li J; Chen CH; O'Neill KL; Fousek-Schuller VJ; Black AR; Black JD; Zhang J; Luo X
    J Biol Chem; 2023 Feb; 299(2):102875. PubMed ID: 36621626
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.